MindImmune Therapeutics, Inc.Amended

Pharmaceuticals · KINGSTON, RI

PharmaceuticalsSEC Form D

MindImmune Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 5, 2026, reporting $15,218,343 raised toward a $17,014,485 offering.

Incorporated in Delaware and based in KINGSTON, RI, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that MindImmune Therapeutics, Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Isaac StonerExecutive Officer · Director
  • Bradley MargusDirector
  • Christopher O'DonnellDirector
  • Reetika BhardwajDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
MindImmune Therapeutics, Inc. raised $15.2M — SEC Form D